Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUID: Lemborexant for Sleep Management in Older Japanese Adults With Insomnia Disorder
jRCTs041210024Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lemborexant in Insomnia, sponsored by Eisai Co., Ltd. Primary endpoints: Change in objective sleep parameters from baseline to week 4 and Change in objective sleep parameters from baseline to week 12. Started Jul 2021; status: completed.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on jRCTs041210024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041210024.